A Cohort Study in Newly Diagnosed MZL
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Marginal Zone Lymphoma
Related studies linked through entity extraction aliases.
BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL)
- Status
- RECRUITING
- Phase
- PHASE2
Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
- Status
- RECRUITING
- Phase
- PHASE2
AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas
- Status
- RECRUITING
- Phase
- PHASE2
Preliminary Assessment of [18F]BL40 in PET/CT Scans
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
- Status
- RECRUITING
- Phase
- N/A
[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma
- Status
- TERMINATED
- Phase
- PHASE3
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
FT596 in Combination With R-CHOP in Subjects With B-Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types
- Status
- UNKNOWN
- Phase
- N/A
Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Marginal Zone Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Allo HSCT Using RIC and PTCy for Hematological Diseases
- Status
- RECRUITING
- Phase
- PHASE2
Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1